IDiyas

For the Inventor, By the Inventor

Oberursel, Germany

Heinz Hanel

USPTO Granted Patents = 10

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 218(Granted Patents)


Location History:

  • Bad Homburg, DE (1989)
  • Oberursel-Stierstadt, DE (1996)
  • Oberursel, DE (1992 - 1999)

Company Filing History:

goldMedal10 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents
silverMedal1 out of 42 
 
Celltech Limited
 patents
where one patent can have more than one assignee

Years Active: 1989-1999

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5958413 - Use of antibodies to TNF or fragments derived thereof and xanthine (1999-09-28),
2. 5824874 - Antifungal polypeptide and process for its production (1998-10-20),
3. 5589624 - Antifungal polypeptide and process for its production (1996-12-31),
4. 5494658 - Antidandruff agents and cosmetic preparations (1996-02-27),
5. 5421839 - Antifungal polypeptide and process for its production (1995-06-06),
6. 5118500 - Pharmaceutical containing TNF inhibitor (1992-06-02),
7. 4870088 - 1-[1-aryl-1-hydroxy-2-azolyl-ethyl]-1-aryl-cyclopropane derivatives, and (1989-09-26),
8. 4859670 - 2-Azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof, agents (1989-08-22),
9. 4824846 - 2-Azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof, agents (1989-04-25),
10. 4797409 - 1-hydroxy-2-pyridones, a process for their preparation, and medicaments (1989-01-10),

Title: Heinz Hanel: Innovator in Antibody and Antifungal Research

Introduction

Heinz Hanel is a notable inventor based in Oberursel, Germany. He has made significant contributions to the fields of immunology and antifungal research. With a total of 10 patents, Hanel's work has had a considerable impact on therapeutic approaches to various medical conditions.

Latest Patents

Hanel's latest patents include innovative uses of antibodies to tumor necrosis factor (TNF) and xanthine derivatives. One of his notable inventions is a combined preparation for the therapy of disorders associated with high levels of TNF, such as septic shock and inflammatory disorders. This preparation includes an antibody to TNF or a TNF binding fragment, along with a xanthine derivative, specifically Pentoxifylline or similar compounds. Additionally, he has developed an antifungal polypeptide that can be produced through the fermentation of Aspergillus giganteus, which shows promise as an antifungal agent.

Career Highlights

Throughout his career, Heinz Hanel has worked with prominent companies such as Hoechst Aktiengesellschaft and Celltech Limited. His work in these organizations has allowed him to advance his research and contribute to significant innovations in the medical field.

Collaborations

Hanel has collaborated with notable colleagues, including Wolfgang Raether and Walter Dittmar. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Heinz Hanel's contributions to antibody and antifungal research exemplify the importance of innovation in addressing medical challenges. His patents and collaborations reflect a commitment to advancing therapeutic solutions for various health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…